BASF sells food and health performance ingredients business to Louis Dreyfus Company
Divestment is part of BASF’s strategic portfolio optimization
Divestment is part of BASF’s strategic portfolio optimization
Launch of new product range aligns with strategy to diversify into emerging applications with high growth potential
Through our research, we aim to ultimately provide new options for our customers to treat life-threatening infections in livestock
Final stage in licensing OVM-200 from Oxford Vacmedix in the UK
2023 Nobel laureates discovered how pseudouridine could make mRNA suitable for vaccines
Debut Biotechnology has outstanding enzyme search and design technology and a bio-manufacturing platform (precision fermentation, cell-free synthesis) using those enzymes
The Research by Indian Fellow at the University has major implications for neurodegenerative disease treatments
To create leading company developing medicines targeting metalloenzymes
To focus on providing safer burn treatments for women and armed forces
Subscribe To Our Newsletter & Stay Updated